vTv Therapeutics Inc. (VTVT) stock
VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)
Close on Nov 17, 2026Market cap $68.37MP/E –Yield –
vTv Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
vTv Therapeutics's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0. The highest annual figure on record is $15.32M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2021 | Dec 31, 2021 | $256.00K | +204.8% |
| FY2020 | Dec 31, 2020 | $84.00K | -41.7% |
| FY2019 | Dec 31, 2019 | $144.00K | -97.8% |
| FY2018 | Dec 31, 2018 | $6.55M | -57.3% |
| FY2017 | Dec 31, 2017 | $15.32M | +38.5% |
| FY2016 | Dec 31, 2016 | $11.06M | +388.2% |
| FY2014 | Dec 31, 2014 | $2.27M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q4 FY2021 | Dec 31, 2021 | $256.00K | -85.1% |
| Q4 FY2020 | Dec 31, 2020 | $84.00K | -96.2% |
| Q3 FY2020 | Sep 30, 2020 | $334.00K | -91.7% |
| Q4 FY2019 | Dec 31, 2019 | $144.00K | -97.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.72M | -81.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.19M | -79.9% |
| Q1 FY2019 | Mar 31, 2019 | $4.01M | -69.3% |
| Q4 FY2018 | Dec 31, 2018 | $6.55M | -57.3% |
| Q3 FY2018 | Sep 30, 2018 | $9.04M | -47.5% |
| Q2 FY2018 | Jun 30, 2018 | $10.86M | -41.3% |
| Q1 FY2018 | Mar 31, 2018 | $13.09M | -30.2% |
| Q4 FY2017 | Dec 31, 2017 | $15.32M | +38.5% |
| Q3 FY2017 | Sep 30, 2017 | $17.23M | – |
| Q2 FY2017 | Jun 30, 2017 | $18.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.06M | – |
See a number that looks wrong?